Weiting Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Weiting Liu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Kaijian Hou
School of Public Health, Shantou University, Shantou, China
4 shared publications Sunjuan Dong
School of Nursing, Anhui University of Chinese Medicine, Hefei, China
4 shared publicationsChi Wang
School of Nursing, Anhui University of Chinese Medicine, Hefei, China
3 shared publicationsLi Wu
School of Nursing, Anhui University of Chinese Medicine, Hefei, China
3 shared publicationsShuo Zhang
Shantou University Medical College, Shantou, Guangdong, China
3 shared publicationsYanling Zhou
School of Nursing, Anhui University of Chinese Medicine, Hefei, China
3 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0339843
Association between nighttime sleep duration trajectories and frailty in middle-aged and older adults: A work-in-progress model based on a CHARLS cohort
Background: Frailty is a major public health issue that impairs the quality of life and health outcomes of middle-aged and older adults. Changes in sleep patterns may play a critical role in the development of frailty. However, studies on the relationship between nighttime sleep duration trajectories and frailty risk remain limited. This study aimed to explore this association and provide preliminary evidence for frailty prevention and intervention. Methods: Data were obtained from 8083 participants aged ≥ 45 years in the China Health and Retirement Longitudinal Study (CHARLS), assessed at four time points over seven years. Latent class trajectory modeling was applied to identify distinct nighttime sleep duration trajectories. Frailty was measured using a frailty index comprising 32 health deficits. Logistic regression was used to evaluate the associations between sleep trajectories and frailty. Results: This study identified two nighttime sleep duration trajectories: normal stable trajectory group, encompassing 7137 (88.2%) individuals, and short with gradual increasing trajectory group, including 946 (11.7%) individuals. Compared with normal stable trajectory group, participants in short with gradual increasing trajectory group had a significantly higher incidence of frailty. Furthermore, after adjusting for covariates, this association remained statistically significant, although the effect size was modest. Conclusions: Long-term exposure to short sleep may be associated with an elevated risk factor for frailty in middle-aged and older adults. Given the modest effect sizes observed, these findings should be interpreted as exploratory and part of a work-in-progress model. Continuous monitoring of sleep duration may still offer insights for early screening and prevention of frailty.
- 30 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0339843
Open AccessAssociation between nighttime sleep duration trajectories and frailty in middle-aged and older adults: A work-in-progress model based on a CHARLS cohort
Background: Frailty is a major public health issue that impairs the quality of life and health outcomes of middle-aged and older adults. Changes in sleep patterns may play a critical role in the development of frailty. However, studies on the relationship between nighttime sleep duration trajectories and frailty risk remain limited. This study aimed to explore this association and provide preliminary evidence for frailty prevention and intervention. Methods: Data were obtained from 8083 participants aged ≥ 45 years in the China Health and Retirement Longitudinal Study (CHARLS), assessed at four time points over seven years. Latent class trajectory modeling was applied to identify distinct nighttime sleep duration trajectories. Frailty was measured using a frailty index comprising 32 health deficits. Logistic regression was used to evaluate the associations between sleep trajectories and frailty. Results: This study identified two nighttime sleep duration trajectories: normal stable trajectory group, encompassing 7137 (88.2%) individuals, and short with gradual increasing trajectory group, including 946 (11.7%) individuals. Compared with normal stable trajectory group, participants in short with gradual increasing trajectory group had a significantly higher incidence of frailty. Furthermore, after adjusting for covariates, this association remained statistically significant, although the effect size was modest. Conclusions: Long-term exposure to short sleep may be associated with an elevated risk factor for frailty in middle-aged and older adults. Given the modest effect sizes observed, these findings should be interpreted as exploratory and part of a work-in-progress model. Continuous monitoring of sleep duration may still offer insights for early screening and prevention of frailty.
- Open Access
- 5 December 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Exploring the relationship between sleep quality, anxiety, depression and frailty in older adults with stroke: a latent profile and mediation analysis
Stroke patients often experience reduced sleep quality, and sleep disturbances not only impair the rehabilitation process but may also increase the risk of
- 5 December 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Open AccessExploring the relationship between sleep quality, anxiety, depression and frailty in older adults with stroke: a latent profile and mediation analysis
Stroke patients often experience reduced sleep quality, and sleep disturbances not only impair the rehabilitation process but may also increase the risk of
- Open Access
- 24 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1699157
Construction and validation of a predictive model for post-operative kinesiophobia in total hip arthroplasty patients
Background: Total hip arthroplasty (THA) is an effective treatment for end-stage hip disease, which can significantly relieve pain, rebuild joint function, and improve patients’ quality of life. Early post-operative functional exercises are essential to promote the recovery of hip function and minimize complications. However, some patients are afraid of exercise due to the risk of pain or dislocation of the prosthesis, resulting in poor adherence to rehabilitation exercises. Kinesiophobia has now become a key factor hindering the rehabilitation process and leading to poor functional recovery. Therefore, early identification of high-risk groups and implementation of targeted interventions are essential to improve patient prognosis. Objectives: To construct and validate a risk prediction model for post-operative kinesiophobia in total hip arthroplasty (THA) patients. Methods: This study is a single-center cross-sectional study with only internal validation. Through the convenience sampling method, 205 patients who underwent total hip arthroplasty (THA) at the Second Affiliated Hospital of Shandong First Medical University from October 2024 to May 2025 were selected as the study subjects. Independent predictors associated with the occurrence of kinesiophobia were screened by univariate analysis and multifactorial logistic regression analysis. A nomogram risk prediction model was constructed using R software, and the Hosmer-Lemeshow test, receiver operating characteristic (ROC) curve, area under the curve (AUC), calibration curves, and decision analysis curves (DCA) were used to evaluate the model’s goodness-of-fit, discriminability, calibration, and clinical utility, respectively. The Bootstrap method was used to perform 1,000 repeated samplings for internal validation of the model. Results: A total of 126 out of 205 post-operative THA patients developed kinesiophobia, and the incidence of kinesiophobia was 61.5%. Logistic regression showed that pain history duration, anxiety, hip function, coping style, and rehabilitation self-efficacy were the influencing factors for the development of kinesiophobia in post-operative patients with THA ( P < 0.05). The AUC value of the constructed model was 0.947 (95% CI 0.919∼0.975), the specificity was 0.873, and the sensitivity was 0.911. The Hosmer-Lemeshow test (χ 2 = 2.287, P = 0.971) and the calibration curve showed that the predicted probability of the model was consistent with the probability of the actual occurrence, and the model predicted the effect well; the DCA curve indicates that the model has good clinical utility. Internal validation using the Bootstrap method yielded an AUC value of 0.912 (95% CI 0.875–0.949). Conclusion: THA patients with a pain history duration (> 1 year), anxiety, poor hip function, low active coping, and poor rehabilitation self-efficacy are more likely to develop kinesiophobia after surgery. The constructed model has good predictive efficacy, which is helpful for early clinical identification of high-risk patients and provides a reference for developing individualized interventions.
- 24 November 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1699157
Open AccessConstruction and validation of a predictive model for post-operative kinesiophobia in total hip arthroplasty patients
Background: Total hip arthroplasty (THA) is an effective treatment for end-stage hip disease, which can significantly relieve pain, rebuild joint function, and improve patients’ quality of life. Early post-operative functional exercises are essential to promote the recovery of hip function and minimize complications. However, some patients are afraid of exercise due to the risk of pain or dislocation of the prosthesis, resulting in poor adherence to rehabilitation exercises. Kinesiophobia has now become a key factor hindering the rehabilitation process and leading to poor functional recovery. Therefore, early identification of high-risk groups and implementation of targeted interventions are essential to improve patient prognosis. Objectives: To construct and validate a risk prediction model for post-operative kinesiophobia in total hip arthroplasty (THA) patients. Methods: This study is a single-center cross-sectional study with only internal validation. Through the convenience sampling method, 205 patients who underwent total hip arthroplasty (THA) at the Second Affiliated Hospital of Shandong First Medical University from October 2024 to May 2025 were selected as the study subjects. Independent predictors associated with the occurrence of kinesiophobia were screened by univariate analysis and multifactorial logistic regression analysis. A nomogram risk prediction model was constructed using R software, and the Hosmer-Lemeshow test, receiver operating characteristic (ROC) curve, area under the curve (AUC), calibration curves, and decision analysis curves (DCA) were used to evaluate the model’s goodness-of-fit, discriminability, calibration, and clinical utility, respectively. The Bootstrap method was used to perform 1,000 repeated samplings for internal validation of the model. Results: A total of 126 out of 205 post-operative THA patients developed kinesiophobia, and the incidence of kinesiophobia was 61.5%. Logistic regression showed that pain history duration, anxiety, hip function, coping style, and rehabilitation self-efficacy were the influencing factors for the development of kinesiophobia in post-operative patients with THA ( P < 0.05). The AUC value of the constructed model was 0.947 (95% CI 0.919∼0.975), the specificity was 0.873, and the sensitivity was 0.911. The Hosmer-Lemeshow test (χ 2 = 2.287, P = 0.971) and the calibration curve showed that the predicted probability of the model was consistent with the probability of the actual occurrence, and the model predicted the effect well; the DCA curve indicates that the model has good clinical utility. Internal validation using the Bootstrap method yielded an AUC value of 0.912 (95% CI 0.875–0.949). Conclusion: THA patients with a pain history duration (> 1 year), anxiety, poor hip function, low active coping, and poor rehabilitation self-efficacy are more likely to develop kinesiophobia after surgery. The constructed model has good predictive efficacy, which is helpful for early clinical identification of high-risk patients and provides a reference for developing individualized interventions.
- Open Access
- 7 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (45) , e45718
Causal relationship between sarcopenia and cognitive performance: A bidirectional Mendelian randomization study
With the acceleration of global population aging, sarcopenia (SA) and cognitive impairment have become major public health concerns. Observational studies suggest associations between them, but such findings may be biased by confounding and reverse causation. Previous Mendelian randomization (MR) studies have yielded inconsistent results. Therefore, this study applied a bidirectional MR design to clarify their causal relationships. We obtained genetic instrumental variables for SA-related traits, including hand grip strength, lean mass, and usual walking pace, from the UK Biobank. Data on cognitive performance were derived from a large genome-wide association studies meta-analysis published in Nature Genetics in 2018 (n = 257,841), with replication performed in an independent cohort from the IEU Open genome-wide association studies database (n = 22,593). Bidirectional MR analyses were primarily conducted using the inverse variance weighted method, supplemented by MR Egger, weighted median, and weighted mode approaches to validate robustness. Heterogeneity and pleiotropy were evaluated by Cochran Q and MR Egger intercept tests, while leave-one-out and Steiger directionality tests assessed robustness. Inverse variance weighted analysis demonstrated significant positive causal effects of genetically predicted right hand grip strength (odds ratio [OR] = 1.112, 95% confidence interval [CI]: 1.032–1.198, P = .005), right arm fat-free mass (OR = 1.060, 95% CI: 1.021–1.100, P = .002), left arm fat-free mass (OR = 1.046, 95% CI: 1.008–1.085, P = .017), right leg fat-free mass (OR = 1.060, 95% CI: 1.023–1.098, P = .001), left leg fat-free mass (OR = 1.050, 95% CI: 1.014–1.087, P = .006), whole body fat-free mass (OR = 1.081, 95% CI: 1.045–1.119, P < .001), and walking pace (OR = 1.414, 95% CI: 1.172–1.705, P < .001) on cognitive performance. In the reverse MR analysis, no significant causal effects of cognitive performance on SA-related traits were observed, except for walking pace. Genetic prediction of SA-related traits may indicate that cognitive impairment is a potential pathogenic factor. Monitoring the muscle health of older adults and preventing the onset or progression of SA could potentially slow cognitive decline. Furthermore, bidirectional MR results suggest a strong causal relationship between walking pace and cognitive performance.
- 7 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (45) , e45718
Open AccessCausal relationship between sarcopenia and cognitive performance: A bidirectional Mendelian randomization study
With the acceleration of global population aging, sarcopenia (SA) and cognitive impairment have become major public health concerns. Observational studies suggest associations between them, but such findings may be biased by confounding and reverse causation. Previous Mendelian randomization (MR) studies have yielded inconsistent results. Therefore, this study applied a bidirectional MR design to clarify their causal relationships. We obtained genetic instrumental variables for SA-related traits, including hand grip strength, lean mass, and usual walking pace, from the UK Biobank. Data on cognitive performance were derived from a large genome-wide association studies meta-analysis published in Nature Genetics in 2018 (n = 257,841), with replication performed in an independent cohort from the IEU Open genome-wide association studies database (n = 22,593). Bidirectional MR analyses were primarily conducted using the inverse variance weighted method, supplemented by MR Egger, weighted median, and weighted mode approaches to validate robustness. Heterogeneity and pleiotropy were evaluated by Cochran Q and MR Egger intercept tests, while leave-one-out and Steiger directionality tests assessed robustness. Inverse variance weighted analysis demonstrated significant positive causal effects of genetically predicted right hand grip strength (odds ratio [OR] = 1.112, 95% confidence interval [CI]: 1.032–1.198, P = .005), right arm fat-free mass (OR = 1.060, 95% CI: 1.021–1.100, P = .002), left arm fat-free mass (OR = 1.046, 95% CI: 1.008–1.085, P = .017), right leg fat-free mass (OR = 1.060, 95% CI: 1.023–1.098, P = .001), left leg fat-free mass (OR = 1.050, 95% CI: 1.014–1.087, P = .006), whole body fat-free mass (OR = 1.081, 95% CI: 1.045–1.119, P < .001), and walking pace (OR = 1.414, 95% CI: 1.172–1.705, P < .001) on cognitive performance. In the reverse MR analysis, no significant causal effects of cognitive performance on SA-related traits were observed, except for walking pace. Genetic prediction of SA-related traits may indicate that cognitive impairment is a potential pathogenic factor. Monitoring the muscle health of older adults and preventing the onset or progression of SA could potentially slow cognitive decline. Furthermore, bidirectional MR results suggest a strong causal relationship between walking pace and cognitive performance.
- Open Access
- 28 May 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1364545
Relationship between gut microbiota and the pathogenesis of gestational diabetes mellitus: a systematic review
Introduction: Gestational diabetes mellitus (GDM) is a form of gestational diabetes mellitus characterized by insulin resistance and abnormal function of pancreatic beta cells. In recent years, genomic association studies have revealed risk and susceptibility genes associated with genetic susceptibility to GDM. However, genetic predisposition cannot explain the rising global incidence of GDM, which may be related to the increased influence of environmental factors, especially the gut microbiome. Studies have shown that gut microbiota is closely related to the occurrence and development of GDM. This paper reviews the relationship between gut microbiota and the pathological mechanism of GDM, in order to better understand the role of gut microbiota in GDM, and to provide a theoretical basis for clinical application of gut microbiota in the treatment of related diseases.Methods: The current research results on the interaction between GDM and gut microbiota were collected and analyzed through literature review. Keywords such as "GDM", "gut microbiota" and "insulin resistance" were used for literature search, and the methodology, findings and potential impact on the pathophysiology of GDM were systematically evaluated.Results: It was found that the composition and diversity of gut microbiota were significantly associated with the occurrence and development of GDM. Specifically, the abundance of certain gut bacteria is associated with an increased risk of GDM, while other changes in the microbiome may be associated with improved insulin sensitivity. In addition, alterations in the gut microbiota may affect blood glucose control through a variety of mechanisms, including the production of short-chain fatty acids, activation of inflammatory pathways, and metabolism of the B vitamin group.Discussion: The results of this paper highlight the importance of gut microbiota in the pathogenesis of GDM. The regulation of the gut microbiota may provide new directions for the treatment of GDM, including improving insulin sensitivity and blood sugar control through the use of probiotics and prebiotics. However, more research is needed to confirm the generality and exact mechanisms of these findings and to explore potential clinical applications of the gut microbiota in the management of gestational diabetes. In addition, future studies should consider the interaction between environmental and genetic factors and how together they affect the risk of GDM.
- 28 May 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1364545
Open AccessRelationship between gut microbiota and the pathogenesis of gestational diabetes mellitus: a systematic review
Introduction: Gestational diabetes mellitus (GDM) is a form of gestational diabetes mellitus characterized by insulin resistance and abnormal function of pancreatic beta cells. In recent years, genomic association studies have revealed risk and susceptibility genes associated with genetic susceptibility to GDM. However, genetic predisposition cannot explain the rising global incidence of GDM, which may be related to the increased influence of environmental factors, especially the gut microbiome. Studies have shown that gut microbiota is closely related to the occurrence and development of GDM. This paper reviews the relationship between gut microbiota and the pathological mechanism of GDM, in order to better understand the role of gut microbiota in GDM, and to provide a theoretical basis for clinical application of gut microbiota in the treatment of related diseases.Methods: The current research results on the interaction between GDM and gut microbiota were collected and analyzed through literature review. Keywords such as "GDM", "gut microbiota" and "insulin resistance" were used for literature search, and the methodology, findings and potential impact on the pathophysiology of GDM were systematically evaluated.Results: It was found that the composition and diversity of gut microbiota were significantly associated with the occurrence and development of GDM. Specifically, the abundance of certain gut bacteria is associated with an increased risk of GDM, while other changes in the microbiome may be associated with improved insulin sensitivity. In addition, alterations in the gut microbiota may affect blood glucose control through a variety of mechanisms, including the production of short-chain fatty acids, activation of inflammatory pathways, and metabolism of the B vitamin group.Discussion: The results of this paper highlight the importance of gut microbiota in the pathogenesis of GDM. The regulation of the gut microbiota may provide new directions for the treatment of GDM, including improving insulin sensitivity and blood sugar control through the use of probiotics and prebiotics. However, more research is needed to confirm the generality and exact mechanisms of these findings and to explore potential clinical applications of the gut microbiota in the management of gestational diabetes. In addition, future studies should consider the interaction between environmental and genetic factors and how together they affect the risk of GDM.
- Open Access
- 28 October 2022
- Published by Springer Nature in Molecular Cancer
- Vol. 21 (1) , 1-32
Antioxidants in brain tumors: current therapeutic significance and future prospects
Brain cancer is regarded among the deadliest forms of cancer worldwide. The distinct tumor microenvironment and inherent characteristics of brain tumor cells virtually render them resistant to the majority of conventional and advanced therapies. Oxidative stress (OS) is a key disruptor of normal brain homeostasis and is involved in carcinogenesis of different forms of brain cancers. Thus, antioxidants may inhibit tumorigenesis by preventing OS induced by various oncogenic factors. Antioxidants are hypothesized to inhibit cancer initiation by endorsing DNA repair and suppressing cancer progression by creating an energy crisis for preneoplastic cells, resulting in antiproliferative effects. These effects are referred to as chemopreventive effects mediated by an antioxidant mechanism. In addition, antioxidants minimize chemotherapy-induced nonspecific organ toxicity and prolong survival. Antioxidants also support the prooxidant chemistry that demonstrate chemotherapeutic potential, particularly at high or pharmacological doses and trigger OS by promoting free radical production, which is essential for activating cell death pathways. A growing body of evidence also revealed the roles of exogenous antioxidants as adjuvants and their ability to reverse chemoresistance. In this review, we explain the influences of different exogenous and endogenous antioxidants on brain cancers with reference to their chemopreventive and chemotherapeutic roles. The role of antioxidants on metabolic reprogramming and their influence on downstream signaling events induced by tumor suppressor gene mutations are critically discussed. Finally, the review hypothesized that both pro- and antioxidant roles are involved in the anticancer mechanisms of the antioxidant molecules by killing neoplastic cells and inhibiting tumor recurrence followed by conventional cancer treatments. The requirements of pro- and antioxidant effects of exogenous antioxidants in brain tumor treatment under different conditions are critically discussed along with the reasons behind the conflicting outcomes in different reports. Finally, we also mention the influencing factors that regulate the pharmacology of the exogenous antioxidants in brain cancer treatment. In conclusion, to achieve consistent clinical outcomes with antioxidant treatments in brain cancers, rigorous mechanistic studies are required with respect to the types, forms, and stages of brain tumors. The concomitant treatment regimens also need adequate consideration.
- 28 October 2022
- Published by Springer Nature in Molecular Cancer
- Vol. 21 (1) , 1-32
Open AccessAntioxidants in brain tumors: current therapeutic significance and future prospects
Brain cancer is regarded among the deadliest forms of cancer worldwide. The distinct tumor microenvironment and inherent characteristics of brain tumor cells virtually render them resistant to the majority of conventional and advanced therapies. Oxidative stress (OS) is a key disruptor of normal brain homeostasis and is involved in carcinogenesis of different forms of brain cancers. Thus, antioxidants may inhibit tumorigenesis by preventing OS induced by various oncogenic factors. Antioxidants are hypothesized to inhibit cancer initiation by endorsing DNA repair and suppressing cancer progression by creating an energy crisis for preneoplastic cells, resulting in antiproliferative effects. These effects are referred to as chemopreventive effects mediated by an antioxidant mechanism. In addition, antioxidants minimize chemotherapy-induced nonspecific organ toxicity and prolong survival. Antioxidants also support the prooxidant chemistry that demonstrate chemotherapeutic potential, particularly at high or pharmacological doses and trigger OS by promoting free radical production, which is essential for activating cell death pathways. A growing body of evidence also revealed the roles of exogenous antioxidants as adjuvants and their ability to reverse chemoresistance. In this review, we explain the influences of different exogenous and endogenous antioxidants on brain cancers with reference to their chemopreventive and chemotherapeutic roles. The role of antioxidants on metabolic reprogramming and their influence on downstream signaling events induced by tumor suppressor gene mutations are critically discussed. Finally, the review hypothesized that both pro- and antioxidant roles are involved in the anticancer mechanisms of the antioxidant molecules by killing neoplastic cells and inhibiting tumor recurrence followed by conventional cancer treatments. The requirements of pro- and antioxidant effects of exogenous antioxidants in brain tumor treatment under different conditions are critically discussed along with the reasons behind the conflicting outcomes in different reports. Finally, we also mention the influencing factors that regulate the pharmacology of the exogenous antioxidants in brain cancer treatment. In conclusion, to achieve consistent clinical outcomes with antioxidant treatments in brain cancers, rigorous mechanistic studies are required with respect to the types, forms, and stages of brain tumors. The concomitant treatment regimens also need adequate consideration.
- Open Access
- 19 October 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1029890
Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review
Gut microbiota plays an important role in the proper functioning of human organisms, while its dysbiosis is associated with disease in various body organs. Diabetes mellitus (DM) is a set of heterogeneous metabolic diseases characterized by hyperglycemia caused by direct or indirect insulin deficiency. There is growing evidence that gut microbiota dysbiosis is closely linked to the development of DM. Gut microbiota composition changes in type 1 diabetes mullites (T1DM) and type 2 diabetes mullites (T2DM) patients, which may cause gut leakiness and uncontrolled entry of antigens into the circulation system, triggering an immune response that damages the isle β cells or metabolic disorders. This review summarizes gut microbiota composition in healthy individuals and compares it to diabetes mullites patients. The possible pathogenesis by which gut microbiota dysbiosis causes DM, particularly gut leakiness and changes in gut microbiota metabolites is also discussed. It also presents the process of microbial-based therapies of DM.
- 19 October 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1029890
Open AccessRole of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review
Gut microbiota plays an important role in the proper functioning of human organisms, while its dysbiosis is associated with disease in various body organs. Diabetes mellitus (DM) is a set of heterogeneous metabolic diseases characterized by hyperglycemia caused by direct or indirect insulin deficiency. There is growing evidence that gut microbiota dysbiosis is closely linked to the development of DM. Gut microbiota composition changes in type 1 diabetes mullites (T1DM) and type 2 diabetes mullites (T2DM) patients, which may cause gut leakiness and uncontrolled entry of antigens into the circulation system, triggering an immune response that damages the isle β cells or metabolic disorders. This review summarizes gut microbiota composition in healthy individuals and compares it to diabetes mullites patients. The possible pathogenesis by which gut microbiota dysbiosis causes DM, particularly gut leakiness and changes in gut microbiota metabolites is also discussed. It also presents the process of microbial-based therapies of DM.
- Open Access
- 8 March 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-6
Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients
Objective. Oxidative stress factors and proinflammatory cytokines had been found to be involved in the pathogenesis of patients with tardive dyskinesia (TD). This study assumes that blood biochemical markers would have a link with TD in schizophrenia patients. To explore the correlation between blood biochemical markers and tardive dyskinesia in patients with schizophrenia (SCH). Methods. From January 2010 to August 2021, the inpatients who met the diagnostic criteria of schizophrenia in the Chinese Classification and Diagnosis Criteria of Mental Disorders (DSM-4) and the American Diagnostic and Statistical Manual of Mental Disorders (DSM-4) were followed up in the psychiatric outpatient department of Jinxia Street Community Health Service Center, Longhu District, Shantou City. The diagnostic criteria of Abnormal Involuntary Movement Scale (AIMS) used in the TD study of Schooler and Kane were used to screen the patients. Patients were divided into the schizophrenia (SCH group) and the schizophrenia with TD groups (TD group). Oxidative stress factors including Superoxide Dismutase1 (SOD1), Glutathione Peroxidase1 (GPX1), Malondialdehyde1 (MDA1), Catalase Activity1 (CAT1), and brain-derived neurotrophic factor 1 (BDNF1) and some inflammatory cytokines including interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), serum tumor necrosis factor (TNF-α), prolactin, estrogen, and cortisol were measured in 121 schizophrenic patients with tardive dyskinesia and 118 schizophrenic patients. The correlation analysis was conducted on the data. Results. Age and female were immutable risk factors for the development of TD, and there were significant differences in blood biochemical indices GPX1, MDA1, CAT1, and TNF-α in schizophrenic patients with and without TD. Conclusion. This study supports that oxidative stress and immune disorders are associated with TD patients. Blood biochemical markers GPX1, MDA1, CAT1, and TNF-α may play an important role in the pathogenesis of schizophrenia combined with TD patients, and they may be useful in the diagnosis of schizophrenia with tardive dyskinesia.
- 8 March 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-6
Open AccessCorrelation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients
Objective. Oxidative stress factors and proinflammatory cytokines had been found to be involved in the pathogenesis of patients with tardive dyskinesia (TD). This study assumes that blood biochemical markers would have a link with TD in schizophrenia patients. To explore the correlation between blood biochemical markers and tardive dyskinesia in patients with schizophrenia (SCH). Methods. From January 2010 to August 2021, the inpatients who met the diagnostic criteria of schizophrenia in the Chinese Classification and Diagnosis Criteria of Mental Disorders (DSM-4) and the American Diagnostic and Statistical Manual of Mental Disorders (DSM-4) were followed up in the psychiatric outpatient department of Jinxia Street Community Health Service Center, Longhu District, Shantou City. The diagnostic criteria of Abnormal Involuntary Movement Scale (AIMS) used in the TD study of Schooler and Kane were used to screen the patients. Patients were divided into the schizophrenia (SCH group) and the schizophrenia with TD groups (TD group). Oxidative stress factors including Superoxide Dismutase1 (SOD1), Glutathione Peroxidase1 (GPX1), Malondialdehyde1 (MDA1), Catalase Activity1 (CAT1), and brain-derived neurotrophic factor 1 (BDNF1) and some inflammatory cytokines including interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), serum tumor necrosis factor (TNF-α), prolactin, estrogen, and cortisol were measured in 121 schizophrenic patients with tardive dyskinesia and 118 schizophrenic patients. The correlation analysis was conducted on the data. Results. Age and female were immutable risk factors for the development of TD, and there were significant differences in blood biochemical indices GPX1, MDA1, CAT1, and TNF-α in schizophrenic patients with and without TD. Conclusion. This study supports that oxidative stress and immune disorders are associated with TD patients. Blood biochemical markers GPX1, MDA1, CAT1, and TNF-α may play an important role in the pathogenesis of schizophrenia combined with TD patients, and they may be useful in the diagnosis of schizophrenia with tardive dyskinesia.
- Open Access
- 28 February 2022
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 22 (4) , 635-642
Association between fasting blood glucose and thyroid stimulating hormones and suicidal tendency and disease severity in patients with major depressive disorder
Thyroid dysfunction and diabetes are reported to be associated with depression. However, their role in the suicide risk in patients with major depressive disorder (MDD) is unclear. The purpose of this study was to investigate and compare thyroid dysfunction and diabetes between suicide attempters and non-suicide attempters in a large sample of first-episode drug-naïve (FEND) MDD patients. A descriptive study was conducted on 1279 Chinese outpatients with a diagnosis of first-episode MDD. Their sociodemographic information, blood levels of thyroid hormones, glucose, lipids and body mass index (BMI) parameters were collected. The positive subscales of the positive and negative syndrome scale (PANSS), Hamilton Anxiety Rating Scale (HAMA), Hamilton Depression Rating Scale (HAMD) were measured for psychotic, anxiety and depressive symptoms. Our results showed that compared with non-suicide attempters (P<0.01), suicide attempters had statistically higher scores on HAMD, HAMA and PANSS psychotic symptoms, as well as higher thyroid stimulating hormone (TSH) serum levels, glucose, anti-thyroglobulin (A-TG), anti-thyroid peroxidase (A-TPO), total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), systolic blood pressure and diastolic blood pressure (all with P<0.001). These results revealed that TSH, A-TG, A-TPO, TC, TG and LDL-C may be promising biomarkers of suicide risk in MDD, implying the importance of regular assessment of blood glucose level and thyroid function parameters for suicide prevention, along with possible treatment for impaired thyroid function and diabetes for the suicide intervention in MDD patients. Such patients with abnormal blood sugar and TSH must undergo thorough screening for suicidal ideation.
- 28 February 2022
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 22 (4) , 635-642
Open AccessAssociation between fasting blood glucose and thyroid stimulating hormones and suicidal tendency and disease severity in patients with major depressive disorder
Thyroid dysfunction and diabetes are reported to be associated with depression. However, their role in the suicide risk in patients with major depressive disorder (MDD) is unclear. The purpose of this study was to investigate and compare thyroid dysfunction and diabetes between suicide attempters and non-suicide attempters in a large sample of first-episode drug-naïve (FEND) MDD patients. A descriptive study was conducted on 1279 Chinese outpatients with a diagnosis of first-episode MDD. Their sociodemographic information, blood levels of thyroid hormones, glucose, lipids and body mass index (BMI) parameters were collected. The positive subscales of the positive and negative syndrome scale (PANSS), Hamilton Anxiety Rating Scale (HAMA), Hamilton Depression Rating Scale (HAMD) were measured for psychotic, anxiety and depressive symptoms. Our results showed that compared with non-suicide attempters (P<0.01), suicide attempters had statistically higher scores on HAMD, HAMA and PANSS psychotic symptoms, as well as higher thyroid stimulating hormone (TSH) serum levels, glucose, anti-thyroglobulin (A-TG), anti-thyroid peroxidase (A-TPO), total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), systolic blood pressure and diastolic blood pressure (all with P<0.001). These results revealed that TSH, A-TG, A-TPO, TC, TG and LDL-C may be promising biomarkers of suicide risk in MDD, implying the importance of regular assessment of blood glucose level and thyroid function parameters for suicide prevention, along with possible treatment for impaired thyroid function and diabetes for the suicide intervention in MDD patients. Such patients with abnormal blood sugar and TSH must undergo thorough screening for suicidal ideation.
- Open Access
- 10 September 2021
- Published by Springer Nature in Cureus
- Vol. 13 (9)
Serum Sickness-Like Reactions After Pneumococcal Vaccination
Serum sickness or serum sickness-like reactions (SSLRs) constitute a rare complication that manifests in individuals after receiving vaccinations. In this case report, we present a patient with typical symptoms of SSLRs after pneumococcal vaccination. The time course of this disease and our diagnostic process are documented in detail. The literature related to serum sickness and SSLRs is also reviewed.
- 10 September 2021
- Published by Springer Nature in Cureus
- Vol. 13 (9)
Open AccessSerum Sickness-Like Reactions After Pneumococcal Vaccination
Serum sickness or serum sickness-like reactions (SSLRs) constitute a rare complication that manifests in individuals after receiving vaccinations. In this case report, we present a patient with typical symptoms of SSLRs after pneumococcal vaccination. The time course of this disease and our diagnostic process are documented in detail. The literature related to serum sickness and SSLRs is also reviewed.